DigiClinics

Hyderabad, India Founded: 2017 • Age: 9 yrs Minicorn
Breast cancer grading and diagnostics are enabled by AI platform.

About DigiClinics

DigiClinics is a Healthcare company based in Hyderabad (India) founded in 2017 by Devika Rubi, Raj Subramanian, and Sheikh Mukhtar. Breast cancer grading and diagnostics are enabled by AI platform. DigiClinics has raised $119.91 thousand across 2 funding rounds from investors including TIH IIT Patna. The company has 1 employees. DigiClinics was last valued at $4.45 million in June 2024. Its chief executive, as recorded, is Raj Subramanian. DigiClinics offers products and services including OncoVision, Digitized Pathology Platform, and Ultrasound and Mammography Platform. Its focus areas include HealthTech, Healthcare IT, Provider and Clinical Operations. Its legal entity in India is Digiclinics Research & Services Private Limited (U73200TN2021PTC146746). Its competitors include Niramai and D3S Healthcare Technologies; 1 of its 2 listed competitors has raised funding.

Company details

Founded in 2017 and based in Hyderabad, India, DigiClinics operates in the healthcare sector with an AI-driven platform for cancer diagnostics. Services include decision support for pathologists in breast and lung cancer cases, where grading is combined with biomarker identification. Clinical workflows are streamlined to support precision medicine, with operations focused on timely treatment delivery across healthcare settings.

  • Headquarters Hyderabad, India
  • Employees 1
  • Founders Devika Rubi, Raj Subramanian, Sheikh Mukhtar
  • Stage Minicorn
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website digiclinics.in
  • Social LinkedIn
  • Legal Name Digiclinics Research & Services Private Limited
  • Date of Incorporation 01 Oct, 2021
  • Jurisdiction Tiruchirappalli, Tamil Nadu, India
Key Metrics
  • Annual Revenue
    ₹16,536

    FY 2024

  • Net Loss
    -₹37.6 Lakh

    FY 2024 · -22728% margin

  • EBITDA
    -₹30.6 Lakh

    FY 2024 · -18515% margin

  • Total Equity Funding
    $119.91K (USD)

    in 2 rounds

  • Latest Funding Round
    $59.74K (USD), Seed

    Jun 2024

  • Investors
  • Employee Count
    1

Products & Services of DigiClinics

DigiClinics offers a comprehensive portfolio of products and services, including OncoVision, Digitized Pathology Platform, and Ultrasound and Mammography Platform.

OncoVision
AI Workflow Platform

Platform for breast cancer diagnostics and efficient grading

Digitized Pathology Platform
Diagnostics Tool

Enables accurate sentinel lymph node metastasis diagnosis

Ultrasound and Mammography Platform
Imaging Tool

Facilitates cost-effective annual breast cancer checkups

Funding Insights of DigiClinics

DigiClinics has successfully raised a total of $119.91K across 2 strategic funding rounds. The most recent funding activity was a Seed round of $59.74 thousand completed in June 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $119,907
  • Total Rounds 2
  • Last Round Seed β€” $59,740
  • First Round $60,167

    (Sep 2023)

  • Investors Count 1

All 2 funding rounds of DigiClinics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jun 2024$59,740Seed$4.45MTIH IIT Patna
–
Sep 2023$60,167Seed$4.41MTIH IIT Patna
–
Valuation history
DateValuationStage
Jun 2024$4.45Mβ€’β€’β€’β€’β€’β€’β€’β€’
Sep 2023$4.41Mβ€’β€’β€’β€’β€’β€’β€’β€’

Last known valuation $4.45M (Jun 2024). 1 investors in total: 1 institutional.

Investors in DigiClinics

DigiClinics has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include TIH IIT Patna.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
tih-iitp.com
Premium access

Investor details for DigiClinics

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Digiclinics Research & Services Private Limited (DigiClinics)

Digiclinics Research & Services Private Limited is the primary company behind DigiClinics. The board of Digiclinics Research & Services Private Limited currently have 2 directors; the longest-serving is Subramanian Rajasekaran, appointed in 2021.

DirectorDesignationAppointedTenureEntity
Subramanian Rajasekaran
DIN 07739696
Director01 Oct 20215 yrs 1 moDigiclinics Research & Services Private Limited
Devika Rubi Rajasekaran
DIN 09344375
Director01 Oct 20215 yrs 1 moDigiclinics Research & Services Private Limited

People of DigiClinics

3 people are tracked at DigiClinics (3 in leadership); the tracked headcount is 1.

NameRoleGroup
Co-Founder & CSOLeadership
Raj Subramanian
Co-Founder & CEOLeadership
Sheikh Mukhtar
Co-FounderLeadership
Premium access

Complete people profiles for DigiClinics

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of DigiClinics

Figures of Digiclinics Research & Services Private Limited, the primary company behind DigiClinics, for FY 2024. Revenue was ₹16,536. Net loss was -₹37.6 Lakh (-22728% margin). EBITDA was -₹30.6 Lakh (-18515% margin).

  • ₹16,536Revenue · FY 2024
  • -₹37.6 LakhNet loss · -22728% margin
  • -₹30.6 LakhEBITDA · -18515% margin
  • ₹1 LakhPaid-up capital

Balance sheet, profit and loss, cash flow and ratios of Digiclinics Research & Services Private Limited are on its company page.

Premium access

Detailed financial statements for DigiClinics

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of DigiClinics

4 dated milestones of DigiClinics across 7 years, from founding to its latest funding, stage changes and deals.

  1. Founded DigiClinics is founded.
  2. Funding First funding round of $60K.
  3. Milestone Reaches Minicorn status.
  4. Funding Latest funding round, Seed, of $60K.

Competitors of DigiClinics

DigiClinics has 2 listed competitors in our database, 1 of them funded. They include Niramai and D3S Healthcare Technologies.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
niramai.com2016Bengaluru, India$8.63M37
Early breast cancer is detected using AI-based non-invasive thermal imaging.
d3shealthcare.com2020Ahmedabad, India
Breast cancer screening devices are supplied to hospitals and clinics.
Premium access

Detailed competitors of DigiClinics

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about DigiClinics

DigiClinics was founded in 2017 and raised its 1st funding round 6 years after it was founded.

DigiClinics is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.

Raj Subramanian is the CEO of DigiClinics, as recorded in our data. They have also founded this company.

DigiClinics is a funded company, having raised a total of $119.91K across 2 funding rounds to date. The company's 1st funding round was a Seed of $60.17K, raised on Sep 2023.

DigiClinics has 1 employees.

The primary company behind DigiClinics, Digiclinics Research & Services Private Limited, reported revenue of β‚Ή16,536 for FY 2024.

Founded in 2017 and based in Hyderabad, India, DigiClinics operates in the healthcare sector with an AI-driven platform for cancer diagnostics. Services include decision support for pathologists in breast and lung cancer cases, where grading is combined with biomarker identification. Clinical workflows are streamlined to support precision medicine, with operations focused on timely treatment delivery across healthcare settings.

DigiClinics's top competitors include Niramai and D3S Healthcare Technologies.

DigiClinics offers OncoVision, Digitized Pathology Platform, and Ultrasound and Mammography Platform.

DigiClinics has 1 investor. Key investors include TIH IIT Patna.

The valuation of DigiClinics is $4.45M as of Jun 2024.

DigiClinics operates through Digiclinics Research & Services Private Limited.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available